Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.06 USD | +2.91% | +1.21% | -26.86% |
May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Financials (USD)
Sales 2024 * | 77.3M | Sales 2025 * | 88.6M | Capitalization | 259M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.93 x |
P/E ratio 2024 * |
-38.1
x | P/E ratio 2025 * |
-273
x | Employees | 108 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.95% |
Latest transcript on Sanara MedTech Inc.
1 day | +2.91% | ||
1 week | +1.21% | ||
Current month | +1.21% | ||
1 month | -9.24% | ||
3 months | -17.69% | ||
6 months | -15.47% | ||
Current year | -26.86% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 30.06 | +2.91% | 11,107 |
24-06-06 | 29.21 | +4.88% | 33,640 |
24-06-05 | 27.85 | -1.59% | 19,212 |
24-06-04 | 28.3 | -0.88% | 27,460 |
24-06-03 | 28.55 | -3.87% | 31,242 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.86% | 259M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.77% | 248B | |
-1.96% | 219B | |
+10.92% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- SMTI Stock